Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2023
Transcanal Endoscopic Management of Middle Ear Paragangliomas.
Многоцентровое исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Surmelioglu Ozgur, Bajin Munir Demir, Kaya Isa, Okuyucu Semsettin, Ozturk Kayhan, Orhan Kadir Serkan, Karlıdag Turgut, Ardıc Fazil Necdet, Ozdek Ali, Yorgancılar Ediz, Dagkiran Muhammed, Celik Mehmet
Аннотация
OBJECTIVE: To evaluate the clinical and audiological outcomes of transcanal endoscopic resection of middle ear paragangliomas.
STUDY DESIGN: Retrospective multicenter study.
SETTING: Tertiary referral center and private otology clinic.
PATIENTS: Patients who underwent transcanal endoscopic surgery between January 2015 and September 2020.
INTERVENTIONS: Transcanal endocope-assisted resection of middle ear paragangliomas.
MAIN OUTCOME MEASURES: Demographic data.
RESULTS: Twenty-three patients (2 men, 21 women) with a mean (standard deviation [SD]) age of 50.5 (11.8) years and stage 1 or 2 disease were included in the study. The mean follow-up time was 2.7 years (range, 1-5 yr). Preoperatively, the mean (SD) air-conduction threshold was 33.8 (17.9) dB, and the mean (SD) air-bone gap was 13.1 (13.9) dB. Postoperatively, the mean (SD) air-conduction threshold was 25.7 (10.2) dB, the mean (SD) air-bone gap was 6.3 (6.1) dB. The mean (SD) hospital stay was 27.7 (9.9) hours. No tumor regrowth was detected on magnetic resonance imaging during postoperative follow-up.
CONCLUSIONS: Endoscopic transcanal tumor resection is effective and feasible in the treatment of stage 1 and 2 tumors and is associated with short operative time, low risk of perioperative and postoperative complications, and rapid discharge.
STUDY DESIGN: Retrospective multicenter study.
SETTING: Tertiary referral center and private otology clinic.
PATIENTS: Patients who underwent transcanal endoscopic surgery between January 2015 and September 2020.
INTERVENTIONS: Transcanal endocope-assisted resection of middle ear paragangliomas.
MAIN OUTCOME MEASURES: Demographic data.
RESULTS: Twenty-three patients (2 men, 21 women) with a mean (standard deviation [SD]) age of 50.5 (11.8) years and stage 1 or 2 disease were included in the study. The mean follow-up time was 2.7 years (range, 1-5 yr). Preoperatively, the mean (SD) air-conduction threshold was 33.8 (17.9) dB, and the mean (SD) air-bone gap was 13.1 (13.9) dB. Postoperatively, the mean (SD) air-conduction threshold was 25.7 (10.2) dB, the mean (SD) air-bone gap was 6.3 (6.1) dB. The mean (SD) hospital stay was 27.7 (9.9) hours. No tumor regrowth was detected on magnetic resonance imaging during postoperative follow-up.
CONCLUSIONS: Endoscopic transcanal tumor resection is effective and feasible in the treatment of stage 1 and 2 tumors and is associated with short operative time, low risk of perioperative and postoperative complications, and rapid discharge.